Literature DB >> 31214827

Evaluation of hearing loss and tinnitus in Behcet's disease.

Ahmet Karadağ1, Mujde Karadağ2, Adem Bora3, Emrullah Hayta4, A Bahadır Çetin5, Sevil C Doğan6, Kasım Durmuş3, E Elif Altuntaş3.   

Abstract

OBJECTIVE: The aim of this study is to evaluate sensorineuralhearing loss (SHNL) and tinnitus in patients with Behcet's disease (BD), while also determining the association between the clinical symptoms of BD and the disease duration with the development of hearing loss.
MATERIALS AND METHODS: The study included 44 patients with BD and 42 healthy volunteers as the control group. The level of tinnitus-induced annoyance and the effects of tinnitus on daily life were evaluated with Visual Analog Scale (VAS) and the Tinnitus Reaction Questionnaire (TRQ). The hearing levels of all participants were measured with high-frequency audiometry and transient auto-acoustic emission tests.
RESULTS: The patients with BD were significantly more affected by SNHL and tinnitus than the controls (p < 0.05). The correlation between disease duration and age among those with SNHL was statistically significant (p < 0.05). No association was found between the clinical findings and SNHL and tinnitus (p > 0.05) in the BD patients.
CONCLUSION: In the present study, high-frequency SNHL was found to be common in among the patients with BD. SNHL in BD is positively correlated with the patients' age of the and the disease duration.

Entities:  

Keywords:  Audiometry; Behcet’s disease; Hearing loss; Tinnitus

Mesh:

Year:  2019        PMID: 31214827     DOI: 10.1007/s00405-019-05506-5

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  27 in total

1.  [The meningoencephalitis of Behcet's disease].

Authors:  T ALAJOUANINE; P CASTAIGNE; F LHERMITTE; J CAMBIER; J C GAUTIER
Journal:  Presse Med       Date:  1961-12-25       Impact factor: 1.228

2.  Tinnitus reaction questionnaire: psychometric properties of a measure of distress associated with tinnitus.

Authors:  P H Wilson; J Henry; M Bowen; G Haralambous
Journal:  J Speech Hear Res       Date:  1991-02

Review 3.  Behçet's disease and complex aphthosis.

Authors:  J V Ghate; J L Jorizzo
Journal:  J Am Acad Dermatol       Date:  1999-01       Impact factor: 11.527

4.  Audiologic pathology in Behçet syndrome.

Authors:  C Andreoli; M Savastano
Journal:  Am J Otol       Date:  1989-11

Review 5.  Behçet's disease: How to diagnose and treat vascular involvement.

Authors:  Emire Seyahi
Journal:  Best Pract Res Clin Rheumatol       Date:  2016-09-16       Impact factor: 4.098

6.  Audiological evaluation in patients with Behçet's disease.

Authors:  N D Sonbay; C Saka; S Tatlican; E Vuralkan; N Aygener; C Eren; I Akin
Journal:  J Laryngol Otol       Date:  2014-07-17       Impact factor: 1.469

7.  Auditory involvement in Behcet's disease: relationship with demographic, clinical, and therapeutic characteristics.

Authors:  Jurgen Sota; Antonio Vitale; Ida Orlando; Giuseppe Lopalco; Rossella Franceschini; Claudia Fabiani; Mauro Galeazzi; Giacomo Emmi; Stefano Gentileschi; Florenzo Iannone; Bruno Frediani; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2016-07-31       Impact factor: 2.980

Review 8.  Hearing loss in autoimmune disorders: Prevalence and therapeutic options.

Authors:  Patrizia Mancini; Francesca Atturo; Alessia Di Mario; Ginevra Portanova; Massimo Ralli; Armando De Virgilio; Marco de Vincentiis; Antonio Greco
Journal:  Autoimmun Rev       Date:  2018-05-03       Impact factor: 9.754

9.  Behçet disease as a cause of hearing loss: A prospective, placebo-controlled study of 29 patients.

Authors:  Ozgur Kemal; Yucel Anadolu; Ayse Boyvat; Ahmet Tatarağası
Journal:  Ear Nose Throat J       Date:  2013-03       Impact factor: 1.697

10.  Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome.

Authors:  H Yazici; Y Tüzün; H Pazarli; S Yurdakul; Y Ozyazgan; H Ozdoğan; S Serdaroğlu; M Ersanli; B Y Ulkü; A U Müftüoğlu
Journal:  Ann Rheum Dis       Date:  1984-12       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.